在新生小鼠中,desisobutyryl-ciclesonide是一种选择性葡萄糖皮质体受体调节剂,其生理和结构特征
Juliann D Jaumotte1, Nathalie El Khoury1, Charles K Min2,3
1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA.
PNAS nexus
|January 9, 2025
概括
奇克索尼德的代谢物Desisobutyryl-ciclesonide (Des-CIC) 在治疗支气管肺功能障碍症方面表现有前途. 它有效地减少了炎症,没有德克萨米他的不良影响,提供了更安全的治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
- 分子生物学分子生物学
背景情况:
- 支气管肺功能障碍症 (BPD) 是早产婴儿的慢性肺部疾病.
- 像德甲 (DEX) 一样,葡萄糖皮质类药物 (GC) 可以治疗BPD,但会引起显著的不良影响.
- 西克莱索尼德 (CIC) 是一种GC前药物,具有潜在的更好的安全性.
研究的目的:
- 调查CIC的活性代谢物desisobutyryl-ciclesonide (Des-CIC) 是否对其增强的安全性负责.
- 在新生儿大鼠模型中,将Des-CIC与DEX的疗效和安全性进行比较.
主要方法:
- 新生小鼠接受了DEX,Des-CIC或载体的治疗.
- 测量了体重,血清IGF-1,葡萄糖水平和促炎性细胞因子mRNA表达.
- 在体外研究中评估了GR转活/转抑制,核心调节器结合和分子动力学模拟.
主要成果:
- DEX,但不是Des-CIC,降低了体重,IGF-1水平,并导致高血糖症.
- 在减少促炎性细胞因子mRNA方面,Des-CIC与DEX同样有效.
- 在实验室中,Des-CIC表现出强烈的GR活性,并以独特的信号通路作为GR超级激动剂.
结论:
- 在新生小鼠中,Des-CIC表现出强大的抗炎作用,而没有DEX的不良影响.
- 德斯-CIC是一种潜在的选择性GR调节器,在BPD治疗中具有有利的治疗指数.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
Dose-Response Relationship: Selectivity and Specificity
6.4K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
Structure-Activity Relationships and Drug Design
494
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
494


